Pregnancy outcome following maternal exposure to statins: A multicentre prospective study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 4, 2013, Pages 463-471

  Winterfeld, U ^a   Allignol, A ^b   Panchaud, A ^a   Rothuizen, L E ^a   Merlob, P ^c   Cuppers Maarschalkerweerd, B ^d   Vial, T ^e   Stephens, S ^f   Clementi, M ^g   De Santis, M ^h   Pistelli, A ⁱ   Berlin, M ^j   Eleftheriou, G ^k   Manakova E ^l   Buclin, T ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c TEL AVIV UNIVERSITY   (Israel)

^d Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

^e Centre Antipoison Centre de Pharmacovigilance   (France)

^f UKTIS   (United Kingdom)

^g Servizio di Informazione Teratologica   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ TIS AOU Carreggi   (Italy)

^j ASSAF HAROFEH MEDICAL CENTER   (Israel)

^k Poison Control Center   (Italy)

^l CHARLES UNIVERSITY   (Czech Republic)

more..

Author keywords

Birth defect; hydroxymethyl glutaryl coenzyme A reductase inhibitors; pregnancy; statins

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; BIRTH DEFECT; BIRTH WEIGHT; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPONTANEOUS ABORTION;

ABNORMALITIES, DRUG-INDUCED; ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADULT; BIRTH RATE; CASE-CONTROL STUDIES; EUROPE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MATERNAL AGE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK FACTORS; TERATOGENS;

EID: 84873728092     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12066     Document Type: Article

References (27)

1. Minsker DH, MacDonald JS, Robertson RT, Bokelman DL,. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Teratology 1983; 28: 449-56. (Pubitemid 14220121)
2. Taguchi N, Rubin ET, Hosokawa A, Choi J, Ying AY, Moretti ME, et al. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol 2008; 26: 175-7.
3. Ofori B, Rey E, Berard A,. Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol 2007; 64: 496-509. (Pubitemid 47404298)
4. Manson JM, Freyssinges C, Ducrocq MB, Stephenson WP,. Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy. Reprod Toxicol 1996; 10: 439-46. (Pubitemid 27030088)
5. Pollack PS, Shields KE, Burnett DM, Osborne MJ, Cunningham ML, Stepanavage ME,. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. Birth Defects Res A Clin Mol Teratol 2005; 73: 888-96. (Pubitemid 41742199)
6. Petersen EE, Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen SA,. Maternal exposure to statins and risk for birth defects: A case-series approach. Am J Med Genet A 2008; 146A: 2701-5.
7. Ghidini A, Sicherer S, Willner J,. Congenital abnormalities (VATER) in baby born to mother using lovastatin. Lancet 1992; 339: 1416-7.
8. Hayes A, Gilbert A, Lopez G, Miller W,. Mevacor-a new teratogen? Am J Hum Genet 1995; 57 (Suppl 4): A92.
9. Edison RJ, Muenke M,. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet A 2004; 131: 287-98.
10. Edison RJ, Muenke M,. Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 2004; 350: 1579-82. (Pubitemid 38477791)
11. Roessler E, Muenke M,. How a Hedgehog might see holoprosencephaly. Hum Mol Genet 2003; 1: R15-25. (Pubitemid 36452283)
12. McMahon AP, Ingham PW, Tabin CJ,. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 2003; 53: 1-114. (Pubitemid 137639458)
13. Gibb H, Scialli AR,. Statin drugs and congenital anomalies. Am J Med Genet A 2005; 135: 230-1.
14. Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C,. Using observational cohort data for studying drug effects on pregnancy outcome-methodological considerations. Reprod Toxicol 2008; 26: 36-41.
15. Meister R, Schaefer C,. Statistical methods for estimating the probability of spontaneous abortion in observational studies-analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 2008; 26: 31-5.
16. D'Agostino RB Jr., Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81. (Pubitemid 28466823)
17. McCaffrey DF, Ridgeway G, Morral AR,. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 2004; 9: 403-25. (Pubitemid 40005040)
18. Hirano K, Imbens GW,. Estimation of causal effects using propensity score weighting: An application to data on right heart catheterization. Health Serv Outcomes Res Methodol 2001; 2: 259-78.
19. White IR, Royston P, Wood AM,. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377-99.
20. Rubin DB,. Multiple Imputation For Nonresponse In Surveys. Chichester: Wiley, 1987.
21. Regan L, Rai R,. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 839-54.
22. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189-94.
23. Wang X, Chen C, Wang L, Chen D, Guang W, French J,. Conception, early pregnancy loss, and time to clinical pregnancy: A population-based prospective study. Fertil Steril 2003; 79: 577-84. (Pubitemid 36293455)
24. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M,. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-12. (Pubitemid 30410486)
25. Pasquali R, Gambineri A,. Metabolic effects of obesity on reproduction. Reprod Biomed Online 2006; 12: 542-51. (Pubitemid 43674925)
26. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K,. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: Population based study. BMJ 2002; 325: 1275-6. (Pubitemid 35430583)
27. Savitz DA, Murnane P,. Behavioral influences on preterm birth: A review. Epidemiology 2010; 21: 291-9.